56
Participants
Start Date
February 6, 2014
Primary Completion Date
January 7, 2015
Study Completion Date
January 7, 2015
AR101 powder provided in capsules
Study product formulated to contain peanut protein at different dosage strengths for use as defined in the protocol
Placebo powder provided in capsules
Study product formulated to contain only inactive ingredients for use as defined in the protocol
Mount Sinai Medical Center, New York
The Children's Hospital of Philadelphia, Philadelphia
University of North Carolina, Chapel Hill
Cincinnati Children's Hospital Medical Center, Cincinnati
Arkansas Children's Hospital, Little Rock
Children's Medical Center Dallas, Dallas
UC San Diego, San Diego
Boston Children's Hospital, Boston
Lead Sponsor
Aimmune Therapeutics, Inc.
INDUSTRY